Clustering data with hclust algorithm for Maternal Hypoxemia and oxidative stress in the fetus, newborn, and adult. exercise training for peripheral artery disease (part II) (Study ST000873)
Reversed phase POSITIVE ION MODE (Analysis AN001479)| Metabolite | Structure | F1 | F2 | F3 | F4 | F5 | F6 | F7 | F8 | F9 | F10 | F11 | F12 | F13 | F14 | F15 | F16 | F17 | F18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DHEA | ME230595 | 2.93 | 0.92 | 4.92 | 2.10 | 0.06 | 0.04 | 0.34 | 0.15 | 0.05 | 0.06 | 5.92 | 0.06 | 0.20 | 1.60 | 0.04 | 0.08 | 0.04 | 0.07 |
| AG | ME230600 | 0.33 | 0.13 | 0.22 | 0.22 | 1.13 | 0.54 | 0.80 | 0.68 | 1.02 | 0.64 | 2.15 | 1.28 | 0.32 | 0.57 | 2.55 | 2.38 | 1.31 | 2.77 |
| 10-Nitrolinoleate | ME230588 | 0.75 | 0.62 | 2.31 | 1.75 | 0.41 | 0.22 | 2.10 | 0.63 | 0.46 | 1.40 | 2.31 | 0.85 | 0.45 | 1.18 | 0.73 | 0.51 | 0.54 | 1.52 |
| 9-Nitrooleate | ME230587 | 1.65 | 0.83 | 1.44 | 0.97 | 0.64 | 0.75 | 1.14 | 0.57 | 0.74 | 1.30 | 0.48 | 0.73 | 0.63 | 1.87 | 0.93 | 0.76 | 1.06 | 2.73 |
| LG | ME230599 | 0.43 | 3.75 | 0.50 | 6.15 | 0.22 | 0.01 | 0.30 | 0.07 | 0.19 | 0.05 | 2.92 | 0.21 | 0.01 | 0.76 | 0.88 | 1.06 | 0.31 | 0.54 |
| NO-Gly | ME230596 | 1.30 | 1.95 | 2.03 | 3.40 | 0.00 | NA | 0.10 | NA | 0.00 | 0.00 | NA | NA | 0.00 | NA | 0.10 | 0.06 | 0.12 | 0.17 |
| OG | ME230598 | 2.66 | 1.05 | 3.99 | 5.03 | 0.09 | 0.15 | 0.12 | 0.53 | 0.15 | 0.31 | 1.62 | 0.41 | 0.23 | 0.28 | 0.13 | 0.24 | 0.08 | 0.37 |
| aLEA | ME230591 | 0.16 | 0.65 | 0.30 | 6.54 | 0.03 | 0.00 | 0.16 | 0.01 | 0.07 | 0.01 | 13.34 | 0.14 | 0.01 | 1.58 | 0.01 | 0.04 | 0.03 | 0.04 |
| OEA | ME230589 | 1.29 | 0.64 | 3.56 | 3.60 | 0.07 | 0.08 | 0.16 | 0.14 | 0.16 | 0.16 | 11.00 | 0.16 | 0.14 | 0.94 | 0.04 | 0.04 | 0.05 | 0.03 |
| Dihomo GLA EA | ME230592 | 0.47 | 0.29 | 0.88 | 0.63 | 0.14 | 0.02 | 0.33 | 0.01 | 0.07 | 0.03 | 21.75 | 0.11 | 0.03 | 1.13 | 0.03 | 0.05 | 0.02 | 0.04 |
| NA-Gly | ME230597 | 0.09 | 0.15 | 0.11 | 0.22 | 0.25 | 0.10 | 2.00 | 0.10 | 0.08 | 0.05 | 23.67 | 0.06 | 0.04 | 1.97 | 0.04 | 0.06 | 0.02 | 0.10 |
| LEA | ME230590 | 0.24 | 1.02 | 0.36 | 4.19 | 0.08 | 0.01 | 0.16 | 0.02 | 0.16 | 0.01 | 18.81 | 0.08 | 0.01 | 1.28 | 0.03 | 0.06 | 0.03 | 0.04 |
| AEA | ME230593 | 1.71 | 0.30 | 2.71 | 0.45 | 0.03 | 0.02 | 0.17 | 0.03 | 0.03 | 0.03 | 18.65 | 0.02 | 0.03 | 1.45 | 0.03 | 0.03 | 0.03 | 0.02 |
| DEA | ME230594 | 0.70 | 0.34 | 0.44 | 0.22 | 0.35 | 0.29 | 1.16 | 0.63 | 0.56 | 0.62 | 16.55 | 0.53 | 0.38 | 1.90 | 0.11 | 0.44 | 0.06 | 0.15 |
Factors:
| F1 | Tissue type:Adipose | Treatment group:Hypoxic | Life stage:Fetal |
| F2 | Tissue type:Adipose | Treatment group:Hypoxic | Life stage:New Born |
| F3 | Tissue type:Adipose | Treatment group:Normoxic | Life stage:Fetal |
| F4 | Tissue type:Adipose | Treatment group:Normoxic | Life stage:New Born |
| F5 | Tissue type:Carotid | Treatment group:Hypoxic | Life stage:Adult non-pregnant |
| F6 | Tissue type:Carotid | Treatment group:Hypoxic | Life stage:Fetal |
| F7 | Tissue type:Carotid | Treatment group:Normoxic | Life stage:Adult non-pregnant |
| F8 | Tissue type:Carotid | Treatment group:Normoxic | Life stage:Fetal |
| F9 | Tissue type:Pulmonary Arteries | Treatment group:Hypoxic | Life stage:Adult non-pregnant |
| F10 | Tissue type:Pulmonary Arteries | Treatment group:Hypoxic | Life stage:Fetal |
| F11 | Tissue type:Pulmonary Arteries | Treatment group:Hypoxic | Life stage:New Born |
| F12 | Tissue type:Pulmonary Arteries | Treatment group:Normoxic | Life stage:Adult non-pregnant |
| F13 | Tissue type:Pulmonary Arteries | Treatment group:Normoxic | Life stage:Fetal |
| F14 | Tissue type:Pulmonary Arteries | Treatment group:Normoxic | Life stage:New Born |
| F15 | Tissue type:Uterine Arteries | Treatment group:Hypoxic | Life stage:Adult non-pregnant |
| F16 | Tissue type:Uterine Arteries | Treatment group:Hypoxic | Life stage:Adult pregnant |
| F17 | Tissue type:Uterine Arteries | Treatment group:Normoxic | Life stage:Adult non-pregnant |
| F18 | Tissue type:Uterine Arteries | Treatment group:Normoxic | Life stage:Adult pregnant |
